Digital Health Leader Verana Health Secures $150M Series E Funding Round

01.14.22

Verana Health, a digital health company that delivers quality drug lifecycle and medical practice insights from an exclusive real-world data network, today announced a $150 million Series E funding round led by Johnson & Johnson Innovation – JJDC, Inc. (JJDC) and Novo Growth, the growth-stage investment arm of Novo Holdings. 

Read More

This website uses cookies to collect information in connection with your use of this website. By continuing to use this website, you agree to the use of all our cookies, which includes new versus returning visitors and country location only. We do not collect personal information. Privacy Notice & Terms and Conditions

Accept